Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sequential antimicrobial therapy: a realistic approach to cost containment?

Literature DB >> 10146884

Sequential antimicrobial therapy: a realistic approach to cost containment?

D R Guay.

Abstract

Mesh：

Substances：
Anti-Infective Agents

Year: 1993 PMID： 10146884 DOI： 10.2165/00019053-199303050-00001

Source DB: PubMed Journal: Pharmacoeconomics ISSN： 1170-7690 Impact factor: 4.981

× No keyword cloud information.

19 in total

1. Therapeutic interchange as a cost-containment measure {editorial}.

Authors: L E Achusim
Journal: Pharmacoeconomics Date: 1992-11 Impact factor: 4.981

2. Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis.

Authors: L O Gentry; G G Rodriguez
Journal: Antimicrob Agents Chemother Date: 1990-01 Impact factor: 5.191

3. New oral and parenteral quinolones. A summary.

Authors: H C Neu
Journal: Am J Med Date: 1989-11-30 Impact factor: 4.965

Review 4. Oral ciprofloxacin: a pharmacoeconomic evaluation of its use in the treatment of serious infections.

Authors: J A Balfour; D Faulds
Journal: Pharmacoeconomics Date: 1993-05 Impact factor: 4.981

5. Oral ciprofloxacin versus ceftriaxone for the treatment of urethritis from resistant Neisseria gonorrhoeae in Zambia.

Authors: J P Bryan; S K Hira; W Brady; N Luo; C Mwale; G Mpoko; R Krieg; E Siwiwaliondo; C Reichart; C Waters
Journal: Antimicrob Agents Chemother Date: 1990-05 Impact factor: 5.191

Review 6. Oral fluoroquinolone versus mono- or combination parenteral therapy in the management of bacterial infections: a critical appraisal.

Authors: D R Guay
Journal: DICP Date: 1990-01

7. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics.

Authors: J A Paladino; H E Sperry; J M Backes; J A Gelber; D J Serrianne; T J Cumbo; J J Schentag
Journal: Am J Med Date: 1991-11 Impact factor: 4.965

8. Metronidazole therapy of anaerobic bacteremia, meningitis, and brain abscess.

Authors: J F Warner; R L Perkins; L Cordero
Journal: Arch Intern Med Date: 1979-02

9. A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections.

Authors: C A Hirata-Dulas; D J Stein; D R Guay; R P Gruninger; P K Peterson
Journal: J Am Geriatr Soc Date: 1991-10 Impact factor: 5.562

Sequential antimicrobial therapy: a realistic approach to cost containment?

1. Therapeutic interchange as a cost-containment measure {editorial}.

2. Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis.

3. New oral and parenteral quinolones. A summary.

Review 4. Oral ciprofloxacin: a pharmacoeconomic evaluation of its use in the treatment of serious infections.

5. Oral ciprofloxacin versus ceftriaxone for the treatment of urethritis from resistant Neisseria gonorrhoeae in Zambia.

Review 6. Oral fluoroquinolone versus mono- or combination parenteral therapy in the management of bacterial infections: a critical appraisal.

7. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics.

8. Metronidazole therapy of anaerobic bacteremia, meningitis, and brain abscess.

9. A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections.

10. Economic impact of streamlining antibiotic administration.

Review 1. Formulary management of macrolide antibiotics.

Review 2. Clinical and economic considerations in the use of third-generation oral cephalosporins.

Review 3. Nursing home-acquired pneumonia. Treatment options.

Review 4. Oral ciprofloxacin: a pharmacoeconomic evaluation of its use in the treatment of serious infections.

5. Effect of enteral feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacin.

Review 6. Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.

Review 7. Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.